1.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-83124A, NCI-T83-1418C, T83-1418
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-NMF-I/II, NCI-T83-1154D, T83-1154
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-86H3, NCI-T85-0216D, T85-0216
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: UMCT-1583, NCI-T83-1262C, T83-1262
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: UMCC-8313, NCI-T83-1076W, T83-1076
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: UMCC-8308, NCI-T83-1081W, T83-1081
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-8376A, NCI-T83-1151C, T83-1151
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4583
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3583
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: UMCT-2683, NCI-T83-1308C, T83-1308
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND13, NCI-T84-0441W, T84-0441, IND13
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND14, NCI-T84-0442W, T84-0442, IND14
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND8, NCI-T84-0440W, T84-0440, IND8
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8489, NCI-T84-0397C, T84-0397
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8441, CALGB-8441
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: ICC-85I1, NCI-T84-0544D, T84-0544
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: ICC-85L1, NCI-T84-0542D
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-26V
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1885
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-4886
|
|
21.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: RWGH-8342253, NCI-T83-1056W
|
|
22.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 20 to 75
Sponsor:
Protocol IDs: NCI-W82-0925, W82-0925
|
|
23.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-W82-1366, UMCC-8227
|
|
24.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: JHOC-85091603, NCI-T85-0238W, T85-0238
|
|
25.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: RIH-871, NCI-T86-0300O, T86-0300
|
